BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 29091800)

  • 21. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.
    Saleh M; Bhosale PR; Yano M; Itani M; Elsayes AK; Halperin D; Bergsland EK; Morani AC
    Abdom Radiol (NY); 2022 Sep; 47(9):3078-3100. PubMed ID: 33095312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.
    Modlin IM; Moss SF; Gustafsson BI; Lawrence B; Schimmack S; Kidd M
    Langenbecks Arch Surg; 2011 Dec; 396(8):1145-56. PubMed ID: 21523447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors.
    Stoyianni A; Pentheroudakis G; Pavlidis N
    Cancer Treat Rev; 2011 Aug; 37(5):358-65. PubMed ID: 21481536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
    Thomas KEH; Voros BA; Boudreaux JP; Thiagarajan R; Woltering EA; Ramirez RA
    Oncologist; 2019 Aug; 24(8):1076-1088. PubMed ID: 30635447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital Image Analysis of Ki67 Heterogeneity Improves the Diagnosis and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Zhang M; Tan C; Wang X; Ding X; Zhang B; Yang Z; Wang Y; Sheng W; Huang D
    Mod Pathol; 2023 Jan; 36(1):100017. PubMed ID: 36788066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022).
    Castillón JC; Gordoa TA; Bayonas AC; Carretero AC; García-Carbonero R; Pulido EG; Fonseca PJ; Lete AL; Huerta AS; Plazas JG
    Clin Transl Oncol; 2023 Sep; 25(9):2692-2706. PubMed ID: 37204633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment personalization in gastrointestinal neuroendocrine tumors.
    Borga C; Businello G; Murgioni S; Bergamo F; Martini C; De Carlo E; Trevellin E; Vettor R; Fassan M
    Curr Treat Options Oncol; 2021 Feb; 22(4):29. PubMed ID: 33641005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national database.
    Matsuoka S; Koizumi T; Otsuki K; Tanaka Y; Kanda S; Ide S; Mishima S; Takeda T; Miura K; Eguchi T; Hamanaka K; Shimizu K
    Cancer Epidemiol; 2022 Apr; 77():102116. PubMed ID: 35144127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine Tumors of the Breast.
    Rosen LE; Gattuso P
    Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
    Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
    Kawasaki K; Fujii M; Sato T
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastroenteropancreatic neuroendocrine neoplasms: concepts and related issues].
    Lai M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):5-9, 23. PubMed ID: 27045235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single institutional experience on primary neuroendocrine neoplasms of the kidney: a rare distinct entity.
    Amin M; Trikalinos N; Chatterjee D
    Hum Pathol; 2021 Aug; 114():36-43. PubMed ID: 33891968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.
    Yang L; Lin H; Shen Y; Roy M; Albarracin C; Ding Q; Huo L; Chen H; Wei B; Bu H; Bedrosian I; Wu Y
    Breast Cancer Res Treat; 2023 Nov; 202(1):23-32. PubMed ID: 37566192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.
    Fernandez-Cuesta L; Sexton-Oates A; Bayat L; Foll M; Lau SCM; Leal T
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e390794. PubMed ID: 37229617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G3 GEP NENs category: are basic and clinical investigations well integrated?
    Milione M; Fazio N
    Endocrine; 2018 Apr; 60(1):28-30. PubMed ID: 28733935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.
    Holmager P; Langer SW; Kjaer A; Ringholm L; Garbyal RS; Pommergaard HC; Hansen CP; Federspiel B; Andreassen M; Knigge U
    Curr Treat Options Oncol; 2022 Jun; 23(6):806-817. PubMed ID: 35362798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in Ki67 Labeling Following Treatment of Poorly Differentiated Neuroendocrine Carcinomas: A Potential Diagnostic Pitfall.
    Vyas M; Tang LH; Rekhtman N; Klimstra DS
    Am J Surg Pathol; 2021 Jan; 45(1):25-34. PubMed ID: 33177340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.